Laurion Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Laurion Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-34,600	Closed	-$20.1M	–	754
2024 Q1	$20.1M	Buy	+34,600	New	+$19.4M	0.17%	117
2023 Q2	–	Sell	-1,300	Closed	-$749K	–	694
2023 Q1	$749K	Sell	1,300 -99,300	-99%	-$56M	0.01%	314
2022 Q4	$55.4M	Buy	+100,600	New	+$53.3M	0.26%	102
2020 Q1	–	Sell	-26,000	Closed	-$8.45M	–	1075
2019 Q4	$8.45M	Sell	26,000 -37,500	-59%	-$11.4M	0.07%	241
2019 Q3	$18.5M	Buy	63,500 +1,700	+3%	+$487K	0.14%	161
2019 Q2	$18.1M	Buy	+61,800	New	+$17M	0.18%	133
2019 Q1	–	Sell	-6,300	Closed	-$1.41M	–	1282
2018 Q4	$1.41M	Buy	6,300 +5,100	+425%	+$1.2M	0.02%	487
2018 Q3	$293K	Buy	+1,200	New	+$276K	﹤0.01%	952
2017 Q4	–	Sell	-38,700	Closed	-$7.32M	–	1841
2017 Q3	$7.32M	Buy	38,700 +1,900	+5%	+$344K	0.03%	392
2017 Q2	$6.42M	Buy	36,800 +2,800	+8%	+$470K	0.04%	438
2017 Q1	$5.22M	Buy	34,000 +31,500	+1,260%	+$4.81M	0.04%	411
2016 Q4	$353K	Buy	2,500 +1,800	+257%	+$265K	﹤0.01%	901
2016 Q3	$111K	Sell	700 -25,900	-97%	-$3.99M	﹤0.01%	845
2016 Q2	$3.93M	Buy	+26,600	New	+$3.93M	0.06%	308

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Laurion Capital Management's TMO Position: Q2 2026 in Review

Laurion Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,980 shares — an estimated $1.96M sold.

Laurion Capital Management first reported a position in TMO in Q2 2015 and held it in 21 quarters. The position peaked at $61.5M in Q1 2024. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Laurion Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Laurion Capital Management sold 3,980 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.96M.
Laurion Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 21 quarters.
Laurion Capital Management's Thermo Fisher Scientific position peaked at $61.5M in Q1 2024.
2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.